This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Gilead Sciences, Inc. (NASDAQ: GILD) today announced the pricing of senior unsecured notes in an aggregate principal amount of $4 billion in an underwritten, registered public offering, consisting of three tranches:
$500 million of 2.050% senior notes maturing in April 2019
$1,750 million of 3.700% senior notes maturing in April 2024
$1,750 million of 4.800% senior notes maturing in April 2044
The senior notes are rated A- by Standard & Poor's and Baa1 by Moody's. The offering is expected to close March 7, 2014, subject to customary closing conditions.
Gilead intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of certain of our indebtedness, debt-related payments, working capital and the repurchase of our outstanding common stock pursuant to our authorized share repurchase program.
Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC, Goldman, Sachs & Co. and Wells Fargo Securities, LLC acted as joint book-running managers in the offering. The offering of the securities is being made only by means of a prospectus supplement and the accompanying base prospectus, which is filed as part of Gilead's effective shelf registration statement on Form S-3 (File No. 194298) copies of which may be obtained from:
Merrill Lynch, Pierce, Fenner & Smith Incorporated
J.P. Morgan Securities LLC
222 Broadway, 11th Floor
383 Madison Ave,
New York, NY 10038
New York, NY 10179
Attention: Prospectus Department
Attn: Investment Grade Syndicate Desk
An electronic copy of the prospectus supplement and the accompanying base prospectus may also be obtained at no charge at the Securities and Exchange Commission's website at
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.